Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cavalli

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Delivery|March 5, 2020
Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Francesco Cavalli, Omar S Usmani, et al.
Journal of Asthma and Allergy|May 16, 2022
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety ProfilePaola Rogliani, Francesco Cavalli, Alfredo Chetta, et al.
Expert Opinion on Drug Delivery|June 21, 2023
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPDRossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.
Journal of Clinical Medicine|August 12, 2022
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScorePaola Rogliani, Josuel Ora, Francesco Cavalli, et al.
Pulmonary Pharmacology & Therapeutics|August 3, 2016
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysisPaola Rogliani, Luigino Calzetta, Francesco Cavalli, et al.
Respiratory Research|August 29, 2022
Sex differences in adult asthma and COPD therapy: a systematic reviewPaola Rogliani, Francesco Cavalli, Beatrice Ludovica Ritondo, et al.
Molecular Diagnosis & Therapy|February 11, 2021
Treatable Mechanisms in AsthmaMario Cazzola, Josuel Ora, Francesco Cavalli, et al.
Journal of Experimental Pharmacology|March 24, 2021
New Avenues for Phosphodiesterase Inhibitors in AsthmaMaria Gabriella Matera, Josuel Ora, Francesco Cavalli, et al.
Biologics : Targets & Therapy|September 3, 2021
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary DiseaseMario Cazzola, Josuel Ora, Francesco Cavalli, et al.
Heliyon|July 5, 2022
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological modelsLuigino Calzetta, Elena Pistocchini, Beatrice Ludovica Ritondo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Delivery|March 5, 2020
Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Francesco Cavalli, Omar S Usmani, et al.
Journal of Asthma and Allergy|May 16, 2022
Potential Drawbacks of ICS/LABA/LAMA Triple Fixed-Dose Combination Therapy in the Treatment of Asthma: A Quantitative Synthesis of Safety ProfilePaola Rogliani, Francesco Cavalli, Alfredo Chetta, et al.
Expert Opinion on Drug Delivery|June 21, 2023
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPDRossella Laitano, Luigino Calzetta, Francesco Cavalli, et al.
Journal of Clinical Medicine|August 12, 2022
Comparing the Efficacy and Safety Profile of Triple Fixed-Dose Combinations in COPD: A Meta-Analysis and IBiS ScorePaola Rogliani, Josuel Ora, Francesco Cavalli, et al.
Pulmonary Pharmacology & Therapeutics|August 3, 2016
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysisPaola Rogliani, Luigino Calzetta, Francesco Cavalli, et al.
Respiratory Research|August 29, 2022
Sex differences in adult asthma and COPD therapy: a systematic reviewPaola Rogliani, Francesco Cavalli, Beatrice Ludovica Ritondo, et al.
Molecular Diagnosis & Therapy|February 11, 2021
Treatable Mechanisms in AsthmaMario Cazzola, Josuel Ora, Francesco Cavalli, et al.
Journal of Experimental Pharmacology|March 24, 2021
New Avenues for Phosphodiesterase Inhibitors in AsthmaMaria Gabriella Matera, Josuel Ora, Francesco Cavalli, et al.
Biologics : Targets & Therapy|September 3, 2021
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary DiseaseMario Cazzola, Josuel Ora, Francesco Cavalli, et al.
Heliyon|July 5, 2022
Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological modelsLuigino Calzetta, Elena Pistocchini, Beatrice Ludovica Ritondo, et al.
Pageof 3